TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
QIAGEN DNA Synthesis AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 74,216 | 83,427 | 136,394 |
Financial expenses | 4,693 | 2,374 | 1,694 |
Earnings before taxes | -50,323 | -31,694 | -7,776 |
EBITDA | -38,047 | -22,239 | -1,929 |
Total assets | 150,901 | 138,879 | 156,397 |
Current assets | 84,987 | 72,223 | 80,166 |
Current liabilities | 132,953 | 127,007 | 106,682 |
Equity capital | 17,948 | 11,872 | 49,715 |
- share capital | 189 | 195 | 210 |
Employees (average) | 105 | 97 | 91 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 11.9% | 8.5% | 31.8% |
Turnover per employee | 707 | 860 | 1,499 |
Profit as a percentage of turnover | -67.8% | -38.0% | -5.7% |
Return on assets (ROA) | -30.2% | -21.1% | -3.9% |
Current ratio | 63.9% | 56.9% | 75.1% |
Return on equity (ROE) | -280.4% | -267.0% | -15.6% |
Change turnover | -6,704 | -43,543 | 47,811 |
Change turnover % | -8% | -34% | 54% |
Chg. No. of employees | 8 | 6 | 19 |
Chg. No. of employees % | 8% | 7% | 26% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.